Dimethicone 410 Completed Phase 3 Trials for Mucositis / Head And Neck Cancer / Radiation-Induced Disorder Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care3
clinicaltrials.gov IdentifierTitleDrugs
NCT02480114Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy